Frontlight ResearchEarly access
Trial site
Shanghai Pudong New Area Mental Health Center
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Depression2 trials
- Schizophrenia2 trials
- Insomnia1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University2 trials
- Nanjing Minova Pharmaceutical Co., Ltd.1 trial
- Shanghai Mental Health Center1 trial
- Tongji University1 trial
- Zhejiang Huahai Pharmaceutical Co., Ltd.1 trial
Running trials
Not yet recruiting
Recruiting
dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia
Recruiting
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
Enrolling by invitation
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Schizophrenia2 recruiting
- Depression1 recruiting
- Insomnia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026